You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

premenopausal

Showing 1 - 25 of 1,111
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor Trial (Elacestrant, Triptorelin)

Not yet recruiting
  • Breast Cancer
  • +3 more
  • (no location specified)
Aug 4, 2023

Premenopausal Idiopathic Osteoporosis Trial in New York (Romosozumab Prefilled Syringe [Evenity], Denosumab 60 MG/ML Prefilled

Recruiting
  • Premenopausal Idiopathic Osteoporosis
  • Romosozumab Prefilled Syringe [Evenity]
  • Denosumab 60 MG/ML Prefilled Syringe [Prolia]
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022

Breast Cancer Trial in Tianjin (Dalcelli?Exemestane?Gosserine, Docetaxel for injection?Epirubicin HCl for

Recruiting
  • Breast Cancer
  • Tianjin, Tianjin, China
    Jie Ge
Aug 20, 2023

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

Breast Cancer, Estrogen Receptor Positive Tumor, HER2-negative Breast Cancer Trial in Seoul (Ovarian function suppression with

Not yet recruiting
  • Breast Cancer
  • +4 more
  • Ovarian function suppression with endocrine treatments
  • Seoul, Korea, Korea, Republic of
    Gangnam Severance Hospital
Dec 18, 2022

Health Behavior Trial in Moscow (Creatine Monohydrate Supplementation)

Recruiting
  • Health Behavior
  • Creatine Monohydrate Supplementation
  • Moscow, Idaho
    University of Idaho
Feb 24, 2023

Endometrial Hyperplasia Trial in Saint Louis (Semaglutide, Placebo, Progestin)

Not yet recruiting
  • Endometrial Hyperplasia
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 24, 2023

Osteoporosis Risk Trial in Salerno (bicarbonate-calcium water)

Completed
  • Osteoporosis Risk
  • bicarbonate-calcium water
  • Salerno, Italy
    University of Salerno
May 2, 2023

Breast Density Trial in Stockholm (Z-Endoxifen, Placebo)

Recruiting
  • Breast Density
  • Stockholm, Sweden
    Karma Study Centre
Dec 16, 2022

Breast Cancer Trial (Giredestrant, Giredestrant plus triptorelin, Anastrozole plus triptorelin)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 13, 2023

Premature Ovarian Failure Trial in Fayoum (Goserelin, Chemotherapy)

Enrolling by invitation
  • Premature Ovarian Failure
  • Fayoum, Mesala, Egypt
    Beni Suef university
Dec 8, 2022

Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

Not yet recruiting
  • Hormone-receptor-positive Breast Cancer
  • +3 more
  • Aromatase inhibitor
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Apr 5, 2023

Adult Idiopathic Generalized Osteoporosis Trial in Omaha, New York (Denosumab)

Completed
Has Results
  • Adult Idiopathic Generalized Osteoporosis
  • Omaha, Nebraska
  • +1 more
Nov 15, 2022

Endometrial Hyperplasia, Grade 1 Endometrial Cancer Trial in Saint Louis, Albuquerque, Oklahoma City (Telemedicine behavioral

Not yet recruiting
  • Endometrial Hyperplasia
  • Grade 1 Endometrial Cancer
  • Telemedicine behavioral weight intervention
  • +3 more
  • Saint Louis, Missouri
  • +2 more
Jun 15, 2023

Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

Not yet recruiting
  • Breast Cancer
  • Breast Cancer, Early-Onset
  • (no location specified)
Jan 18, 2023

Breast Cancer Trial in Visakhapatnam (Goserelin acetate 3.6 mg Injection, ZOLADEX® 3.6mg Injection)

Recruiting
  • Breast Cancer
  • Goserelin acetate 3.6 mg Injection
  • ZOLADEX® 3.6mg Injection
  • Visakhapatnam, Andhra Pradesh, India
    Mahatma Gandhi Cancer Hospital & Research Institute
Nov 29, 2022

Breast Cancer Trial (Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression)

Not yet recruiting
  • Breast Cancer
  • Ovarian Function Suppression + Aromatase Inhibitor
  • Adjuvant Chemotherapy + Ovarian Function Suppression
  • (no location specified)
May 19, 2023

Endometriosis Trial (HS-10518, Placebo)

Not yet recruiting
  • Endometriosis
  • (no location specified)
Nov 1, 2023

Breast Tumors, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in United States (Z-endoxifen, exemestane,

Recruiting
  • Breast Neoplasms
  • +3 more
  • Phoenix, Arizona
  • +3 more
Jan 30, 2023

Iron-deficiency Trial in New Farm (Low dose IHAT, High Dose IHAT, Carob flour)

Not yet recruiting
  • Iron-deficiency
  • Low dose IHAT
  • +2 more
  • New Farm, Queensland, Australia
    RDC Clinical Pty Ltd
Jul 14, 2023

Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)

Recruiting
  • Premenopausal Breast Cancer
  • Hormone Receptor-positive Breast Cancer
  • Tamoxifen Oral Product
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 14, 2022

Vitamin D Deficiency, Calcium, Premenopause Trial in Giza (resistive exercise, high intensity interval training, calcium and

Enrolling by invitation
  • Vitamin D Deficiency
  • +2 more
  • resistive exercise
  • +2 more
  • Giza, Egypt
    Faculty of physical therapy
Mar 21, 2023

Lumbar Pain Syndrome, Cervical Pain Trial in Cairo (Myofascial release, Muscle energy technique)

Recruiting
  • Lumbar Pain Syndrome
  • Cervical Pain
  • Myofascial release
  • Muscle energy technique
  • Cairo, Egypt
    Cairo University
Mar 27, 2023

Vulvodynia Trial in Denville (CO2 laser, Lidocaine patch 5%)

Completed
  • Vulvodynia
  • CO2 laser
  • Lidocaine patch 5%
  • Denville, New Jersey
    Garden State Urology
Apr 13, 2022

Breast Cancer Trial in Shanghai (OFS + Anastrozole, OFS + Exemestane)

Completed
  • Breast Cancer
  • OFS + Anastrozole
  • OFS + Exemestane
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Mar 28, 2022